Last reviewed · How we verify

Prednisolone treatment

Barz IVF Center for Infertility Treatment and Embryo Research · Phase 1 active Small molecule

Prednisolone treatment is a Small molecule drug developed by Barz IVF Center for Infertility Treatment and Embryo Research. It is currently in Phase 1 development. Also known as: Experimental.

At a glance

Generic namePrednisolone treatment
Also known asExperimental
SponsorBarz IVF Center for Infertility Treatment and Embryo Research
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Prednisolone treatment

What is Prednisolone treatment?

Prednisolone treatment is a Small molecule drug developed by Barz IVF Center for Infertility Treatment and Embryo Research.

Who makes Prednisolone treatment?

Prednisolone treatment is developed by Barz IVF Center for Infertility Treatment and Embryo Research (see full Barz IVF Center for Infertility Treatment and Embryo Research pipeline at /company/barz-ivf-center-for-infertility-treatment-and-embryo-research).

Is Prednisolone treatment also known as anything else?

Prednisolone treatment is also known as Experimental.

What development phase is Prednisolone treatment in?

Prednisolone treatment is in Phase 1.

Related